Prostate Cancer Care Disparity Analysis Project (ProGAP)
ConditionProstate CA
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAnkara University
About this trial
This international cross-sectional study seeks to evaluate global disparities in prostate cancer management by conducting a thorough comparison of key elements across countries categorized as low-income, lower-middle-income, upper-middle-income, and high-income.
The primary question it addresses is: Are the standards of care for prostate cancer uniformly applied across different geographic regions worldwide? To achieve this, we will recruit physicians specializing in the diagnosis and treatment of prostate cancer from a diverse array of countries within these income classifications. Participants will complete a 17-question online survey.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Healthcare professionals actively treating prostate cancer patients-such as urologists, uro-oncologists, medical oncologists, and radiation oncologists-who specialize in the diagnosis and treatment of prostate cancer, representing a diverse range of countries categorized as low-income, lower-middle-income, upper-middle-income, and high-income
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
No Intervention: Observational Cohort
Other interventionNo Intervention: Observational Cohort
Treatment groups
400 Participants
are divided into 1 treatment groupGroup A: Healthcare professionals for prostate cancer1 intervention
Trial outcomes
Primary outcomes
1
Characterization of global disparities in prostate cancer diagnosis, treatment, and management practices
Comparative analyses will be conducted using survey data to reveal disparities between different regions and healthcare settings. The findings will be presented as percentages of respondents, with territorial and institutional differences thoroughly evaluated. Participants will be categorized into three groups based on the World Bank\'s income classification: low and lower-middle, upper-middle, and high-income countries. Descriptive statistics will be employed to compare demographic characteristics and clinical practices. For categorical data analysis, the Pearson Chi-Square or Fisher\'s Exact test will be utilized, while ANOVA tests will be applied to independent variables. A p-value of less than 0.05 will be considered statistically significant.
Time frame
One monthSecondary outcomes
1
Assessment of access to care, encompassing advanced diagnostic tools, treatment modalities, and patient support services; analysis of adherence to guidelines and its effect on treatment outcomes
Identifying the percentage of healthcare professionals across various geographic regions who have access to diagnostic and treatment methods that align with established guidelines, and evaluating the impact of these methods on treatment outcomes. The findings will be presented as percentages of respondents, with territorial and institutional differences thoroughly examined.
Time frame
One monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov